scholarly journals Antiproliferative Activity of Combined Biochanin A and Ginsenoside Rh2 on MDA-MB-231 and MCF-7 Human Breast Cancer Cells

Molecules ◽  
2018 ◽  
Vol 23 (11) ◽  
pp. 2908 ◽  
Author(s):  
Guixing Ren ◽  
Zhenxing Shi ◽  
Cong Teng ◽  
Yang Yao

Breast cancer is the most frequently diagnosed cancer in women worldwide. The antiproliferative activities of biochanin A (BA) and ginsenoside Rh2 were determined by evaluating their inhibitory effect on MDA-MB-231 human breast cancer cell proliferation. The combination of BA with Rh2 was also assessed. In MDA cells, combination treatment led to a decrease in the EC50 values of BA and Rh2 to 25.20 μM and 22.75 μM, respectively. In MCF-7 cells, the EC50 values of combined BA and Rh2 decreased to 27.68 μM and 25.41 μM, respectively. BA combined with Rh2 also improved the inhibition of MDA-MB-231 and MCF-7 cell migration and invasion compared to the individual compounds. Western blot analysis demonstrated upregulation in p-p53, p-p38, and p-ASK1 proteins while levels of TRAF2 were downregulated. These results suggest that BA combined with Rh2 exhibits synergistic effects against MDA-MB-231 and MCF-7 cell proliferation.

2019 ◽  
Vol 39 (7) ◽  
Author(s):  
Ye Du ◽  
Lishengnan Shen ◽  
Wei Zhang ◽  
Rongbo Ding ◽  
Qian Li ◽  
...  

Abstract MicroRNA-326 (miR-326) was reported to be dysregulated and involved in the progression of multiple cancers. However, the clinical significance, biological role and underlying mechanism of miR-326 in the carcinogenesis of breast cancer are still unclear. In the present study, we showed that miR-326 was down-regulated in human breast cancer tissues and cell lines. Our results also revealed that miR-326 overexpression significantly suppressed breast cancer cell proliferation, migration and invasion, and induced cell cycle arrest at G1/G0 phase. Furthermore, Sex determining region Y-box (SOX) protein 12 (SOX12), a known oncogene, was identified as a direct target of miR-326 by luciferase reporter assay. Moreover, miR-326 expression was inversely correlated with SOX12 mRNA expression levels in human breast cancer specimens. Overexpression of SOX12 partially rescued the inhibitory effect on cell proliferation, migration and invasion in breast cancer cells caused by miR-326 overexpression. These findings suggested that miR-326 might play a suppressive role in breast cancer, at least in part, by targeting SOX12, rendering miR-326 a promising therapeutic target for breast cancer.


2015 ◽  
Vol 2015 ◽  
pp. 1-10 ◽  
Author(s):  
Meng-Wong Taing ◽  
Jean-Thomas Pierson ◽  
Paul N. Shaw ◽  
Ralf G. Dietzgen ◽  
Sarah J. Roberts-Thomson ◽  
...  

The assessment of human cancer cell proliferation is a common approach in identifying plant extracts that have potential bioactive effects. In this study, we tested the hypothesis that methanolic extracts of peel and flesh from three archetypal mango cultivars, Irwin (IW), Nam Doc Mai (NDM), and Kensington Pride (KP), differentially affect proliferation, extracellular signal-regulated kinase (ERK) activity, and intracellular calcium ([Ca2+]I) signalling in MCF-7 human breast cancer cells. Mango flesh extracts from all three cultivars did not inhibit cell growth, and of the peel extracts only NDM reduced MCF-7 cell proliferation. Mango cultivar peel and flesh extracts did not significantly change ERK phosphorylation compared to controls; however, some reduced relative maximal peak[Ca2+]Iafter adenosine triphosphate stimulation, with NDM peel extract having the greatest effect among the treatments. Our results identify mango interfruit and intrafruit (peel and flesh) extract variability in antiproliferative effects and[Ca2+]Isignalling in MCF-7 breast cancer cells and highlight that parts of the fruit (such as peel and flesh) and cultivar differences are important factors to consider when assessing potential chemopreventive bioactive compounds in plants extracts.


2011 ◽  
Vol 112 (1) ◽  
pp. 217-224 ◽  
Author(s):  
Ying-Wei Li ◽  
Guo-Yuan Zhu ◽  
Xiao-Ling Shen ◽  
Jian-Hong Chu ◽  
Zhi-Ling Yu ◽  
...  

2013 ◽  
Vol 32 (12) ◽  
pp. 699-707 ◽  
Author(s):  
Guoqing Zhao ◽  
Jun Guo ◽  
Dong Li ◽  
Chengyou Jia ◽  
Wanzhong Yin ◽  
...  

2020 ◽  
Vol 10 (6) ◽  
pp. 789-797
Author(s):  
Zhaoyan Shi ◽  
Weidong Xiao ◽  
Meifang Hu

Breast cancer (BC) is one of the most prevalent and mortal malignancies in women worldwide, and tamoxifen is the mainstay treatment of breast cancer and the development of resistance represents a major obstacle for a cure. Long non-coding RNAs (LncRNAs) LINC00261 have been identified to serve a key role in the development of several tumors. However, the role of LINC00261 in breast cancer and chemotherapy resistance remains largely unknown. To investigate the role of LINC00261 in BC cells, LINC00261 was upregulated in MCF-7-TAM cells by transfecting with LINC00261 plasmid (pcDNA-LINCC00261). Subsequently, cell viability and drug sensitivity were measured using the CCK-8 assay. Reverse transcription-quantitative polymerase chain reaction (qRT-PCR) was performed to detect the level of LINC00261 in BC cells. Cell migration, invasion, and apoptosis were detected by Transwell, Scratch Test and Flow cytometry, respectively. Additionally, the associated protein expression was detected using Western blot. The results demonstrated that LINC00261 was significantly down-regulated in BC cells, especially in MCF-7-TAM cells. Overexpression of LINC00261 inhibited cell proliferation, migration, and invasion in MCF-7-TAM cells. Further, an abundant of LINC00261 sensitized breast cancer cells to tamoxifen and reduced tamoxifen-induced apoptosis in MCF-7-TAM cells. Finally, LINC00261 significantly regulated the protein expression of drug-resistant genes and the protein expression related to tumor metastasis and cell apoptosis. Therefore, this study revealed that LINC00261 induces chemosensitization to tamoxifen in human breast cancer, it may be a useful biomarker and potential therapeutic target.


Sign in / Sign up

Export Citation Format

Share Document